INTRODUCTION {#sec1-1}
============

Inferior alveolar nerve block (IANB) has been regarded as one of the most technically difficult local anesthesia injections and is clinically adequate in 85-90% of the time in restorative dentistry but its efficacy is reduced to 20% in irreversible pulpitis. An effective local anesthesia is a prerequisite for pain control in endodontics. The IANB is most frequently used mandibular injection technique for achieving local anesthesia for endodontic treatment. Anesthetic failures after IANB have been reported to be between 44% and 81%.\[[@ref1]\] The high rate of failure may be due to accessory innervations, inaccurate injection technique, needle deflection, cross innervations, central core theory.\[[@ref2]\] Patient factors such as variations in anatomy, unpredictable spread of anesthesia, local infection, pulpal inflammation, and psychological issues also affect the effectiveness. In 30-80% of patients with irreversible pulpitis single IANB is ineffective.\[[@ref3]\]

Local infection causes decrease in pH locally and can influence the amount of local anesthesia available in the lipophilic form to diffuse across the nerve membrane. This results in less drug interference of sodium channels. In symptomatic teeth with irreversible pulpitis, one theory regarding the high rate of local anesthetic failure is the prostaglandin induced sensitization of peripheral nociceptors.\[[@ref4][@ref5]\] Pulpal inflammation causes activation and sensitization of peripheral nociceptors leading to sprouting of nerve terminals in the pulp. This leads to expression of different sodium channels: Tetrodotoxin (TTX)-resistant class of sodium channels are four times as resistant to blockade by lidocaine and their expression is doubled in the presence of prostglandin E2 (PGE2).

Earlier studies have suggested that preoperative medication might increase the success rate of the IANB.\[[@ref6]--[@ref8]\] Therefore, there may be some potential for preoperative pain medications to increase the effectiveness of the IANB in patients with irreversible pulpitis.

The purpose of this study was to compare the effect of the administration of preoperative ibuprofen (600 mg), ketorolac (10 mg), combination of etodolac with paracetamol (400 mg + 500 mg), and combination of aceclofenac with paracetamol (100 mg + 500 mg) versus placebo for the potential increased effectiveness of the IANB anesthesia in patients with irreversible pulpitis.

MATERIALS AND METHODS
=====================

Siksha'O' Anusandhan University Research and Ethical Committee approved the study. The study consisted of 100 patients in the age group of 18-65 years consisting of 63 males and 37 females, in acute pain with mandibular molar teeth (first or second molar) diagnosed as acute irreversible pulpitis. Written informed consent was obtained from all human subjects who participated in the experimental investigation after the nature of the procedure and possible discomforts and risks had been fully explained. Patients were questioned regarding inclusion/exclusion criteria. Inclusion criteria were: Between the ages of 18 and 65 years; in good health; informed consent granted; vital mandibular molar teeth. Exclusion criteria were: Allergy to ibuprofen, ketorolac, etodolac, aceclofenac, and paracetamol; history of significant medical problem; gastrointestinal problems; syndrome of nasal polyps; angioedema or bronchospastic reactivity to aspirin or other nonsteroidal antiinflammatory drugs (NSAIDs); taken central nervous system (CNS) depressants (including alcohol or any analgesic medications) within the last 48 hours; pregnancy; lactating; or inability to give informed consent. To qualify for the study, each patient had a vital mandibular tooth, and actively experiencing moderate-to-severe pain (≥85 mm) as determined by a Heft-Parker Visual Analogue Scale (VAS),\[[@ref9]\] and had a prolonged response to cold testing. Patients with no response to cold testing or periradicular pathosis (other than a widened periodontal ligament) were excluded from the study.

Patients were randomly assigned to five groups with 20 patients in each group. Group I were administered placebo with sugar coated pills, Group II were given Ibuprofen (600 mg, Abott), Group III were administered Ketorolac (10 mg, Dr. Reddy\'s), Group IV were given combination of Etodolac with Paracetamol (400 mg + 500 mg, Mankind Pharma), and Group V were given combination of aceclofenac with paracetamol (100 mg + 500 mg, Warren, Indoco).

Cold testing using Green Endo ice spray (Hygenic) was done before administration of anesthesia to determine level of pain on a scale of 1-170 mm using Heft-Parker VAS score. Medication was given 30 minutes before the anesthesia was administered. IANB was administered under aseptic conditions by using 2% lignocaine with 1:100000 adrenaline (Astra Zeneca).

The tooth was then isolated with a clamp and rubber dam and an endodontic access was performed after 15 minutes. There were three phases of the treatment: Access into dentin, access into the pulp chamber, and instrumentation of the canals. Each patient was instructed to rate any discomfort during endodontic treatment using the VAS.

RESULTS {#sec1-2}
=======

[Table 1](#T1){ref-type="table"} shows age group of the patients studied for each group (*P* = 0.326). [Table 2](#T2){ref-type="table"} shows gender distribution for each group. [Table 3](#T3){ref-type="table"} shows initial pain VAS ratings (Heft-Parker scale) before administration of local anesthesia. All the subjects reported moderate-to-severe pain and there was no statistically significant difference between the groups. [Table 4](#T4){ref-type="table"} shows minimum and maximum VAS score and mean and standard deviation of patient\'s pain response during endodontic treatment in the five groups. Analysis of variance (ANOVA) test was applied to detect significant differences at the level of *P* \< 0.5. IANB success by pain type for all the groups is shown in [Table 5](#T5){ref-type="table"}.
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Mean visual analogue scale response to cold test prior to local anesthetic administration for five groups
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Mean visual analogue scale patient response during endodontic treatment for five groups
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Inferior alveolar nerve block failure pain ratings in five groups studied

![](JCD-16-171-g005)

Overall success was 54% for all the groups. Success was 70% for the ketorolac group, 55% for both ibuprofen group and combination of aceclofenac with paracetamol group, 50% for combination of etodolac with paracetamol group, and 40% for the placebo group. Difference in results for Group III (Ketorolac group) was higher as compared with other groups.

DISCUSSION {#sec1-3}
==========

No attempt was made to balance the number of male versus female subjects, nor the ages of the patients. Children under the age of 18 were not included in this study and the results of the study may not be applicable to patients under 18 years of age. Mandibular molar teeth were used exclusively for this study and all teeth were diagnosed with clinical irreversible pulpitis including spontaneous pain, which was rated as moderate to severe.

Though the recording of pain is always subjective, it is probable that the current study had a similar patient pool in terms of initial pain as the other studies\[[@ref1][@ref10]\] with the mean pain ratings being classified as moderate-to-severe in intensity. These findings support the fact that irreversible pulpitis can cause a significant degree of pain.\[[@ref11]\] Therefore, compared with asymptomatic teeth, we would expect a lower IANB success rate. Again, there was no statistically significant difference between the groups with regard to initial pain thus eliminating initial pain as a confounding variable.

Electric pulp testing (EPT) has been used to determine pulpal anesthesia.\[[@ref12][@ref13]\] An EPT is not always an accurate method of determining pulpal anesthesia in teeth with a diagnosis of irreversible pulpitis\[[@ref14]\] and was not used in the current study. Clinical endodontic access gives a clinically relevant determination of pulpal anesthesia and was the method used in the current study to test anesthetic efficacy of the IANB.

The IANB success rate studies done by Cohen *et al*.,\[[@ref1]\] Kennedy *et al*.,\[[@ref10]\] Matthews *et al*.,\[[@ref11]\] Reisman *et al*.,\[[@ref13]\] Claffey *et al*.,\[[@ref15]\] Nusstein *et al*.,\[[@ref16]\] Bigby *et al*.,\[[@ref17]\] and Lindemann *et al*.\[[@ref18]\] suggest that success rate is not adequate for performing clinical endodontic treatment on mandibular posterior teeth. This has historically been a problem and many studies have researched the IANB and supplemental anesthesia techniques to further increase anesthetic success.

Cohen\'s group\[[@ref1]\] studied mandibular posterior irreversible pulpitis teeth and found 23 out of 61 (38%) subjects required supplemental anesthesia because the IANB failed to give adequate anesthesia. The reported IANB success was 62%.

In symptomatic teeth with irreversible pulpitis, one theory regarding the high rate of local anesthetic failure is the prostaglandin induced sensitization of peripheral nociceptors.\[[@ref19]\] Peripheral terminals of nociceptors express receptors that can detect chemical and physical stimuli. This results in activation of various ion channels. Inflammatory mediators such as prostaglandins produce their effects by binding to various protein receptors. Level of prostaglandin is increased in inflamed pulps. Interventions that decrease the overall concentration of prostaglandins, such as administration of ibuprofen, lead to reduced activation of these receptors.\[[@ref20][@ref21]\] Therefore, it appears logical that if the production of prostaglandins is interrupted, it may increase the efficacy of local anesthetics.

Ianiro *et al*.\[[@ref7]\] found a 71% success rate for the acetaminophen group, a 76% success rate for the combination of acetaminophen and ibuprofen, and a 46% success rate for the placebo group. While there were no significant differences between the groups, the authors stated that there was a trend toward higher success in the medication groups.

In the current study also, though not statistically significant we found an increased success of IANB in the premedication groups as compared with the placebo group. The patients who had pain upon endodontic access were given a buccal infiltration of lidocaine. For those patients who continued to have pain after administration of the supplemental anesthetic, other supplemental injections were given, such as intrapulpal injections, periodontal ligament (PDL) injections, and other infiltrations, until emergency endodontic treatment could be completed. Supplemental anesthetic success was not evaluated in the present study.

CONCLUSION {#sec1-4}
==========

Under the limitations of the study, this study confirmed that mandibular anesthesia in symptomatic teeth is difficult to attain with an IANB alone. Administering ketorolac 10 mg, 45 minutes prior to treatment did improve success (70%) as compared with pacebo group (40%) whereas other groups showed no significant success. The use of mandibular buccal infiltration injection given as supplemental anesthesia improved anesthetic success, but was still only moderately successful. Further research is needed to determine more effective means of providing anesthesia for the IANB in patients with irreversible pulpitis.
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